Fig. 1.
Fig. 1. Effects of desmopressin (DDAVP) on von Willebrand factor antigen levels (VWF:Ag), VWF-cleaving protease activity (ADAMTS13), VWF propeptide (VWF:pp), VWF collagen-binding activity (VWF:CBA), and VWF multimers pattern (VWF:MM). / Healthy volunteers (n = 10) received 0.3 μg/kg DDAVP over 30 minutes. VWF:Ag is indicated by ●; ADAMTS13, ○; VWF:CBA, ▴; and VWF:pp, ▵. Data are presented as means ± standard errors of mean. Presence of unusually large (UL) VWF:MM is indicated by +; absence of UL VWF:MM, −.

Effects of desmopressin (DDAVP) on von Willebrand factor antigen levels (VWF:Ag), VWF-cleaving protease activity (ADAMTS13), VWF propeptide (VWF:pp), VWF collagen-binding activity (VWF:CBA), and VWF multimers pattern (VWF:MM).

Healthy volunteers (n = 10) received 0.3 μg/kg DDAVP over 30 minutes. VWF:Ag is indicated by ●; ADAMTS13, ○; VWF:CBA, ▴; and VWF:pp, ▵. Data are presented as means ± standard errors of mean. Presence of unusually large (UL) VWF:MM is indicated by +; absence of UL VWF:MM, −.

Close Modal

or Create an Account

Close Modal
Close Modal